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FIGURE 2. The valve base includes 3 clear, pliable shields that cover the
hooks and prevent the sutures from tangling during insertion. These shields
also act as soft tissue retractors to facilitate greater exposure and visualiza-
tion during attachment of the leaflet set.
Case Reportsmm Hg, and 2.0 mm Hg. Effective orifice areas at that time
were 1.35 cm2, 1.74 cm2, and 1.35 cm2. At 90 days of
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One other report has described an easy-to-insert valve
with separate components for insertion and removal.2 In
our 3-patient cohort, the valve was easy to insert, and the
shields protecting the stent posts facilitated suture tying.
The valve’s leaflets did not obstruct inspection and place-
ment of additional sutures. Overall valve performance was
excellent.
Safety and durability should be assessed in a larger series
of patients. Valve replacement through a transapical
approach is currently being investigated, and a working
engineering model shows that a transapical approach and
leaflet set exchange may be possible.References
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Boston, MassSaphenous vein graft (SVG) aneurysms, especially giant
ones with severe dilatation, are rare and present with non-
specific symptoms. They occur about 1 decade after sur-
gery and can be life-threatening, with an in-hospital
mortality of 15.7%.1 Covered stents have been increas-
ingly used for aneurysm treatment instead of classic surgi-
cal excision.2 The success of the intervention is time
dependent. We report a death from multisystem failure
after delayed SVG aneurysm exclusion using covered
stent grafts.CASE REPORT
An 83-year-old man, who had previously undergone cor-
onary artery bypass grafting 3 decades earlier, underwent
a reoperation for a failed circumflex graft, a stenotic poste-
rior descending artery graft, and aortic valve replacement
for aortic stenosis. His left anterior descending (LAD)
SVG was satisfactory at the time. Three years later, he
underwent repeat cardiac catheterization at another institu-
tion that showed a 100% ostial lesion of the LAD and
a 70% lesion proximal to the distal LAD anastomosis.
A heparin-coated stent was deployed for a 100% ostial
lesion in the right coronary artery. No particularities were
noted regarding the SVG. This was complicated by progres-
sive congestive heart failure, with the ejection fraction
reduced to 35%.
The patient developed hemoptysis, was diagnosed with
bronchitis and bronchiectasis, and was treated with bron-
chodilators and antibiotics. He did not have another epi-
sode until 4 months later, when he presented with
massive hemoptysis. He remained hemodynamically sta-
ble during the transfer to our institution and denied short-
ness of breath or chest pain. Bronchoscopy showed
bleeding in the airway, with right-sided bleeding greaterery c August 2012
FIGURE 1. Computed tomography angiogram of the saphenous vein graft pseudoaneurysm showing partially thrombosed vein graft to left anterior de-
scending artery (white arrows) measuring 6.83 4.93 3.7 cm. A, Right lung changes consistent with hemorrhage. B, Proximal end of saphenous vein graft.
C, Distal end of pseudoaneurysm and graft.
Case Reportsthan the left. A computed tomography angiogram showed
a 6.8 3 4.9 3 3.7-cm partially thrombosed saccular aneu-
rysm arising from the SVG, to the LAD, 2 cm distal to its
proximal anastomosis with hemorrhage concerning for an
aneurysm leak (Figure 1).
The patient was taken urgently to the catheterization lab-
oratory for percutaneous exclusion of the pseudoaneurysm.
A covered stent could not be passed after placement of the
guidewires. The patient was thus transferred to the cardiac
care unit, pending obtaining larger bore catheters. The
patient ultimately underwent successful exclusion of the
aneurysm with placement of 3 overlapping covered
stents over a 7F sheath. No endoleak or extravasation of
dye around the stents was noted after the procedure
(Figure 2). He experienced a myocardial infarction owing
to no-reflow to the LAD. His procedure was complicated
by significant blood loss requiring emergent open repair
of the left brachial arteriotomy with a bovine pericardialFIGURE 2. Coronary angiograms. A, Preintervention coronary angiogram (righ
anterior descending artery dilatation. B, Coronary angiogram (right anterior obl
saphenous vein graft pseudoaneurysm and limited flow to left anterior descend
The Journal of Thoracic and Capatch. The patient subsequently required increasing hemo-
dynamic support, developed respiratory failure, acute kid-
ney failure requiring venovenous hemodialysis, and
ongoing coagulopathy during the next several days. His
family decided to withdraw care in accordance with
his stated wishes, and the patient died 5 days after
presentation.
DISCUSSION
Severe SVG dilatations are large (6  3 cm), occur re-
motely after surgery, and are life-threatening, with high
in-hospital mortality. Hemoptysis and hemothorax are
dreaded complications and can quickly result in death.
True aneurysms are more common than pseudoaneurysms,
which occur in 14% of patients.1,3 These pseudoaneurysms
usually occur at proximal anastomosis sites and are thought
to occur from tension on the anastomosis or technical issues
with suture placement.4t anterior oblique projection) showing proximal saphenous vein graft to left
ique projection) after deployment of 3 covered stents, showing exclusion of
ing artery.
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Case ReportsDifferent treatment options exist for management and
are applied according to the anatomy of the aneurysm
and flow dynamics in the coronary circulation. Repeat cor-
onary artery bypass grafting with aneurysmal excision is
the classic approach. Reports have been published of suc-
cessful stent placement when continued antegrade flow
through the graft is necessary, and coil embolization and
vascular plugs have been used in cases in which this is nei-
ther necessary nor desired.3,5 These can also be particularly
useful in patients in whom the risk of bypass surgery is
high and because a reoperation, although high risk, does
not eliminate the pathologic process of the veins.
Endovascular procedures also have risks, however, and
our patient illustrates 1 of them. The risk of bleeding,
particularly in coagulopathic patients, is real in these
procedures.
Ultimately, the outcomes of SVG aneurysm repair de-
pend on acute recognition of the pathologic features
from high clinical suspicion, obtaining early diagnostic
tests to rule it out, and fast decision making regarding
the approach for repair. The stakes are even greater in pa-
tients with severe dilatation and/or evidence of aneurysmal
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We have described a patient with a giant vein graft aneu-
rysm complicated by a leak and pulmonary hemorrhage.
This diagnosis should be suspected in patients remote
from coronary artery bypass grafting who present with he-
moptysis and can be confirmed by computed tomography
angiography. Covered stents can be successfully used to ex-
clude these aneurysms and should be deployed in a timely
manner to preclude adverse outcomes.
Wewould like to thank Dr Frederic Scott Resnic for performing
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2009;2009:981292.Simultaneous sternal reconstruction and tricuspid valve replacement
in a patient with chronic osteomyelitis and absence of tricuspid valveByung Kwon Chong, MD,a Joon Bum Kim, MD,a and Tae Jin Yun, MD, PhD,b Seoul, Republic of KoreaChronic sternal osteomyelitis is an uncommon complica-
tion of major cardiac surgery and carries significant
morbidity and mortality. If this complication is accom-
panied by severe tricuspid valve (TV) regurgitation
and right heart failure, the management is more chal-
lenging. We report the successful treatment of such
a case by simultaneous TV replacement and sternal
reconstruction.CASE REPORT
A 65-year-old woman with type 2 diabetes mellitus and
hypertension was admitted because of painful swelling of
the anterior chest wall. She had a history of ventricular sep-
tal defect closure 13 years previously. Nine days postoper-
atively, sternal wound revision was done because of a deep
sternal infection. She was readmitted 7 months later with
endocarditis of the TV caused by methicillin-resistant
Staphylococcus aureus and underwent tricuspid valve-
ctomy through a right thoracotomy approach. During the
ensuing 13 years, she experienced 5 episodes of sternal in-
fection, which were treated by soft tissue debridement and
vacuum-assisted closure.
At the present evaluation, she complained of dyspnea
equivalent to New York Heart Association functional class
III with prominent neck vein engorgement. Her temperature
was 38.1C. The sternal woundwas disrupted to a depth of 3
to 4 cm with a purulent discharge. The laboratory findings
included a leukocyte count of 16,000/mm3 (94.6% poly-
morphonuclear cells) and C-reactive protein of 21.13ery c August 2012
